Mesothelioma Treatment Costs Quick Reference
Mesothelioma Treatment Costs Quick Reference
Overview
Mesothelioma treatment is among the most expensive of any cancer diagnosis, with total lifetime costs frequently exceeding $400,000 and reaching $1 million or more.[1] The mean cost per mesothelioma hospitalization is $24,901 based on national hospital discharge data, and patients typically require multiple hospitalizations over the course of treatment.[1] Since the 2020 FDA approval of immunotherapy (Opdivo + Yervoy) as a first-line treatment, average per-patient costs have increased substantially, with the immunotherapy treatment course alone totaling $292,319.[2] Multiple financial assistance programs — including $30+ billion in asbestos trust funds — can help offset these expenses.[3]
Key Facts
| Category | Detail |
|---|---|
| Total Lifetime Cost | $400,000–$1,000,000+[1][4] |
| Mean Hospitalization Cost | $24,901 per episode (2014)[1] |
| Most Expensive Standard Treatment | Immunotherapy: $292,319 total course[2] |
| Most Expensive Surgery | EPP: $62,408 per procedure[1] |
| Standard Chemotherapy (6 cycles) | $38,779–$87,741[1] |
| Radiation Per Course | $7,500–$11,100 median[5] |
| Bankruptcy Risk | Cancer patients 2.65× more likely to file[6] |
| Medicare Part D OOP Cap | $2,000/year (Inflation Reduction Act, 2025)[7] |
| Trust Fund Assets Available | $30+ billion across 60+ trusts[3] |
| Clinical Trial Participation | Less than 5% of mesothelioma patients[8] |
Treatment Cost Comparison
| Treatment | Cost | Measurement |
|---|---|---|
| EPP Surgery | $62,408 | Per procedure[1] |
| P/D Surgery | $53,993 | Per procedure[1] |
| CRS/HIPEC | $38,369 | Average hospital cost[9] |
| Pemetrexed + Cisplatin | $38,779 | 6 cycles drug cost[1] |
| Pemetrexed + Cisplatin + Bevacizumab | $87,741 | 6 cycles drug cost[1] |
| Opdivo + Yervoy | $292,319 | Total treatment course[2] |
| Radiation Therapy | $9,000 | Median per course[5] |
| CAR-T Cell Therapy | $300,000–$475,000 | Per infusion (experimental)[10] |
| TTFields (Optune Lua) | ~$21,000 | Per month[11] |
Frequently Asked Questions
How much does mesothelioma treatment cost?
Total lifetime costs typically range from $400,000 to over $1 million, depending on treatment approach. The mean cost per hospitalization is $24,901, with surgical cases averaging $29,344.[1] Immunotherapy with Opdivo plus Yervoy totals $292,319 over the treatment course.[2]
Does insurance cover mesothelioma treatment?
Most health insurance plans cover standard mesothelioma treatments, though patients face deductibles averaging $1,787 for employer plans.[12] Medicare covers hospice care with no deductible and caps Part D prescription costs at $2,000 per year under the Inflation Reduction Act.[7][13]
What financial help is available for mesothelioma patients?
Patients may access asbestos trust funds ($100,000–$400,000+ combined), personal injury lawsuits, VA disability benefits, SSDI through Compassionate Allowances, and manufacturer assistance programs.[14][3]
Do treatment costs vary by location?
Yes. Northeast U.S. hospitalizations average $33,396, compared to $18,206 in the Midwest — a difference of 83%.[1] U.S. treatment costs are also substantially higher than in most other developed nations.[1]
Can clinical trials reduce treatment costs?
Clinical trial sponsors typically cover investigational drug costs, and insurance must cover routine care under the ACA. However, less than 5% of mesothelioma patients currently participate in clinical trials.[8][15]
Quick Statistics
- Total lifetime mesothelioma treatment costs range from $400,000 to $1,000,000+[1][4]
- Mean hospitalization cost is $24,901 based on 1,675 hospital discharges nationally[1]
- Immunotherapy (Opdivo + Yervoy) costs $292,319 over the full treatment course[2]
- Cancer patients are 2.65 times more likely to file for bankruptcy than non-cancer patients[6]
- Northeast hospital costs are 83% higher than Midwest costs for mesothelioma[1]
- More than $30 billion remains in asbestos trust funds for mesothelioma patients[3]
- 35% of cancer caregivers report stopping work due to caregiving demands[16]
- Less than 5% of mesothelioma patients participate in clinical trials[8]
- Medicare Part D caps prescription out-of-pocket costs at $2,000/year under the Inflation Reduction Act[7]
Get Help
Related Pages
- Mesothelioma Treatment Costs — Comprehensive treatment cost breakdown
- Treatment Options — Overview of all mesothelioma treatments
- Asbestos Trust Funds — Trust fund compensation guide
- Mesothelioma Settlements — Settlement values and process
- Mesothelioma Treatment Centers — Specialized treatment facilities
- Clinical Trials — Current mesothelioma research trials
References
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 Borrelli EP, McGladrigan CG, et al. "Costs of medical care for mesothelioma." Rare Tumors. 2019;11:2036361319863498. https://pmc.ncbi.nlm.nih.gov/articles/PMC6637828/
- ↑ 2.0 2.1 2.2 2.3 2.4 Gao L, Wang J, et al. "Cost-effectiveness of nivolumab plus ipilimumab as first-line therapy for unresectable malignant pleural mesothelioma." Front Public Health. 2022;10:947221. https://pmc.ncbi.nlm.nih.gov/articles/PMC9354521/
- ↑ 3.0 3.1 3.2 3.3 U.S. Government Accountability Office. "Asbestos Injury Compensation: The Role and Administration of Asbestos Trusts." GAO-11-819, September 2011. https://www.gao.gov/products/gao-11-819
- ↑ 4.0 4.1 Mesothelioma Treatment Costs, Mesothelioma Lawyer Center.
- ↑ 5.0 5.1 Paravati AJ, Mell LK, et al. "Variation in the Cost of Radiation Therapy Among Medicare Patients with Cancer." J Oncol Pract. 2015;11(5):403-409. https://pmc.ncbi.nlm.nih.gov/articles/PMC4575405/
- ↑ 6.0 6.1 Zafar SY. "Financial toxicity of cancer care: it's time to intervene." J Natl Cancer Inst. 2016;108(5):djv370. https://pmc.ncbi.nlm.nih.gov/articles/PMC5985271/
- ↑ 7.0 7.1 7.2 Centers for Medicare & Medicaid Services. Medicare Part D out-of-pocket cap under the Inflation Reduction Act. https://www.cms.gov/inflation-reduction-act-and-medicare
- ↑ 8.0 8.1 8.2 Taioli E, Wolf AS, et al. "Patterns of Care and Survival Among Patients with Malignant Mesothelioma in the United States." Lung Cancer. 2018;115:55-60. https://pmc.ncbi.nlm.nih.gov/articles/PMC5726440/
- ↑ Blaj S, Giglia M, et al. "Evaluation of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a community setting." J Surg Oncol. 2016;113(4):461-466. https://pubmed.ncbi.nlm.nih.gov/26750613/
- ↑ American Cancer Society. "CAR T-cell Therapy and Its Side Effects." https://www.cancer.org/cancer/managing-cancer/treatment-types/immunotherapy/car-t-cell.html
- ↑ Mesothelioma Treatment Options, Mesothelioma.net.
- ↑ Kaiser Family Foundation. "2024 Employer Health Benefits Survey." https://www.kff.org/health-costs/report/2024-employer-health-benefits-survey/
- ↑ Medicare.gov. "Medicare and Hospice Benefits: Getting Started." https://www.medicare.gov/publications/11361-medicare-hospice-getting-started.pdf
- ↑ Danziger & De Llano, LLP, Mesothelioma Attorneys.
- ↑ Mesothelioma Treatment, Mesothelioma Lawyer Center.
- ↑ Yoon J, Chee CP, et al. "Working, Low Income, and Cancer Caregiving: Financial and Mental Health Impacts." JCO Oncol Pract. 2023;19(8):e1249-e1260. https://pmc.ncbi.nlm.nih.gov/articles/PMC10414725/
Cite error: <ref> tag with name "nci_ft" defined in <references> is not used in prior text.
This quick reference page is maintained by WikiMesothelioma.com and updated as treatment costs change. Last reviewed: March 2026.